Maria Skłodowska-Curie National Institute of Oncology

The Maria Skłodowska-Curie National Institute of Oncology is today the supreme, multi-site central nervous system of Polish cancer research and ultra-high-tier clinical care. Headquartered at its monumental, highly specialized flagship campus on Roentgena Street in Warsaw, with prominent elite branches in Gliwice and Kraków, this national research institute completely defies the profile of a standard regional hospital. It exists as an authoritative, state-directed scientific mega-complex where deep-tier biomedical innovation is translated into aggressive, personalized tumor-eradication protocols. As the undisputed cornerstone of the national cancer strategy, the institute handles the most structurally complex, treatment-resistant oncological cases in central Europe, orchestrating nationwide screening frameworks while simultaneously pushing the absolute boundaries of global molecular biology. The facility was officially opened in 1932 as the Radium Institute, with the participation of the world-famous, talented Maria Sklodowska-Curie. Currently, it is one of the most important European oncology hospitals, offering a high level of treatment efficiency through collaboration among oncologists and specialists. The clinical and scientific architecture of the flagship complex is characterized by its massive scale and the absolute synchronization of laboratory diagnostics with patient-side therapies. The institute houses a world-class center for genomic mapping and molecular pathology, where high-throughput next-generation sequencing allows multidisciplinary tumor boards to decode the precise genetic mutations of a patient's malignancy before a single drug is administered. This profound focus on translational medicine means that the facility acts as the nation's primary incubator for early-phase clinical trials, offering patients immediate access to avant-garde immunotherapies, targeted monoclonal antibodies, and experimental small-molecule inhibitors that are years away from widespread commercial availability. This systemic chemical vanguard is seamlessly integrated with a massive visceral and surgical oncology department specializing in hyper-extended resections, intraoperative radiotherapy, and complex reconstructive procedures for micro-invasive breast, gynecological, urological, and head-and-neck carcinomas. Highly qualified doctors have treated patients and conducted clinical research at the Institute's oncology center since 2011. The staff consists of laureates of the prestigious Rosalind Franklin Society award in science, winners of the "Doctor of Empathy" plebiscite, winners of Supertalents in Medicine 2022, and top scientists, according to the research website.  The medical staff was also recognized by the ShEO Awards 2021 in the "Medical Authority" category for their special attention to educational activities and support for patients during treatment. The Organization of European Cancer Institutes certificate for 2022 provided opportunities for global cooperation among the most influential centers in modern oncology treatment. Numerous grants for research and cooperation with the Center of Scientific Research made it possible to provide access to the latest and unique treatment for oncological lesions, including stem cell therapy. The hospital also conducts clinical trials in which surgical treatment is combined with other treatments. It is worth noting that the lymphatic system cancer clinic, based at the institute, is the largest and most successful clinic in Poland in the diagnosis and treatment of neoplasms of the lymphatic system. Also, the center of breast tumor and reconstructive surgery is the most experienced center in Poland in the complex treatment of patients after surgical intervention. The institute's absolute technological spearhead remains its legendary, historically unmatched dominance in radiation oncology and nuclear medicine, a direct, evolved continuation of the early radium therapies championed by its founder. The facility operates an unparalleled arsenal of linear accelerators, CyberKnife systems, and stereotactic radiotherapy rigs engineered to deliver high-dose ionization with sub-millimeter precision, effectively melting deep-seated tumors while completely sparing surrounding healthy tissues. Furthermore, its nuclear medicine division is a European frontier for theranostics, utilizing specialized radioisotopes that simultaneously image and target metastatic neuroendocrine tumors and advanced prostate cancers at the cellular level. Maria Skłodowska-Curie National Institute of Oncology is a world-class institution, bringing together a team of leading specialists not only in medicine but also in science. The clinic offers highly accurate diagnosis and effective treatment for patients with cancer from the head, heart, and stomach to the most complex structures: the lymphatic and nervous systems. A robust department of molecular technology has evolved into MicroRNA diagnostics for even more targeted treatment. The study of genetically engineered cancer immunotherapy (CAR-T) demonstrates the potential for a unique treatment even in the most challenging cases.